Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

1.

Cockroach sensitization mitigates allergic rhinoconjunctivitis symptom severity in patients allergic to house dust mites and pollen.

He W, Jimenez F, Martinez H, Harper NL, Manoharan MS, Carrillo A, Ingale P, Liu YG, Ahuja SS, Clark RA, Rather CG, Ramirez DA, Andrews CP, Jacobs RL, Ahuja SK.

J Allergy Clin Immunol. 2015 May 28. pii: S0091-6749(15)00547-3. doi: 10.1016/j.jaci.2015.02.041. [Epub ahead of print]

PMID:
26026342
2.

Early life disadvantage strengthens flight performance trade-offs in European starlings, Sturnus vulgaris.

O'Hagan D, Andrews CP, Bedford T, Bateson M, Nettle D.

Anim Behav. 2015 Apr;102:141-148.

3.

Responsiveness to timothy grass pollen in individuals without known natural exposure in an allergen challenge chamber.

Ramirez DA, Andrews CP, Rather CG, Jacobs RL.

Ann Allergy Asthma Immunol. 2015 Mar;114(3):226-32. doi: 10.1016/j.anai.2014.11.006. Epub 2014 Dec 19.

PMID:
25532737
4.

Symptom dynamics during repeated serial allergen challenge chamber exposures to house dust mite.

Jacobs RL, Andrews CP, Ramirez DA, Rather CG, Harper N, Jimenez F, Martinez H, Manoharan M, Carrillo A, Gerardi M, Esch RE, He W, Ahuja SK.

J Allergy Clin Immunol. 2015 Apr;135(4):1071-5. doi: 10.1016/j.jaci.2014.09.047. Epub 2014 Nov 11. No abstract available.

PMID:
25458003
5.

Long-term efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol.

Weinstein SF, Andrews CP, Shah SR, Chylack LT Jr, Tankelevich A, Ding Y, Tantry SK.

Allergy Asthma Proc. 2014 Jul-Aug;35(4):323-31. doi: 10.2500/aap.2014.35.3767.

PMID:
24992552
6.

Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.

Giles TD, Weber MA, Basile J, Gradman AH, Bharucha DB, Chen W, Pattathil M; NAC-MD-01 Study Investigators.

Lancet. 2014 May 31;383(9932):1889-98. doi: 10.1016/S0140-6736(14)60614-0.

PMID:
24881993
7.

Effect of confounding cofactors on responses to pollens during natural season versus pollen challenge chamber exposure.

Jacobs RL, Harper N, He W, Andrews CP, Rather CG, Ramirez DA, Ahuja SK.

J Allergy Clin Immunol. 2014 May;133(5):1340-6, 1346.e1-7. doi: 10.1016/j.jaci.2013.09.051. Epub 2013 Dec 9.

PMID:
24331377
8.

The mountain cedar model in clinical trials of seasonal allergic rhinoconjunctivitis.

Andrews CP, Ratner PH, Ehler BR, Brooks EG, Pollock BH, Ramirez DA, Jacobs RL.

Ann Allergy Asthma Immunol. 2013 Jul;111(1):9-13. doi: 10.1016/j.anai.2013.05.004. Epub 2013 May 31.

PMID:
23806453
9.

Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes.

Jacobs RL, Harper N, He W, Andrews CP, Rather CG, Ramirez DA, Ahuja SK.

J Allergy Clin Immunol. 2012 Jul;130(1):122-7.e8. doi: 10.1016/j.jaci.2012.03.031. Epub 2012 May 1.

PMID:
22554707
10.

Validation of the biogenics research chamber for Juniperus ashei (mountain cedar) pollen.

Jacobs RL, Ramirez DA, Andrews CP.

Ann Allergy Asthma Immunol. 2011 Aug;107(2):133-8. doi: 10.1016/j.anai.2011.04.009. Epub 2011 May 14.

PMID:
21802021
11.

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.

Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators.

Eur Respir J. 2010 Jul;36(1):65-73. doi: 10.1183/09031936.00127809. Epub 2010 Feb 25.

12.

Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.

Zuwallack R, De Salvo MC, Kaelin T, Bateman ED, Park CS, Abrahams R, Fakih F, Sachs P, Pudi K, Zhao Y, Wood CC; Combivent Respimat Inhaler Study Group.

Respir Med. 2010 Aug;104(8):1179-88. doi: 10.1016/j.rmed.2010.01.017. Epub 2010 Feb 20.

13.

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators.

Lancet. 2009 Oct 3;374(9696):1171-8. doi: 10.1016/S0140-6736(09)61298-8. Epub 2009 Aug 27.

PMID:
19716598
14.

Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy.

Andrews CP, Martin BG, Jacobs RL, Mohar DE, Diaz JD, Amar NJ, Kaiser HB, Vandewalker ML, Bernstein J, Toler WT, Prillaman BA, Dalal AA, Lee LA, Philpot EE.

Allergy Asthma Proc. 2009 Mar-Apr;30(2):128-38. doi: 10.2500/aap.2009.30.3204.

PMID:
19463203
15.

Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.

Bergallo C, Jasovich A, Teglia O, Oliva ME, Lentnek A, de Wouters L, Zlocowski JC, Dukart G, Cooper A, Mallick R; 308 Study Group.

Diagn Microbiol Infect Dis. 2009 Jan;63(1):52-61. doi: 10.1016/j.diagmicrobio.2008.09.001. Epub 2008 Nov 5.

PMID:
18990531
16.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators.

N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.

17.

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.

Tanaseanu C, Bergallo C, Teglia O, Jasovich A, Oliva ME, Dukart G, Dartois N, Cooper CA, Gandjini H, Mallick R; 308 Study Group; 313 Study Group.

Diagn Microbiol Infect Dis. 2008 Jul;61(3):329-38. doi: 10.1016/j.diagmicrobio.2008.04.009. Epub 2008 May 27.

PMID:
18508226
18.

Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.

Tashkin DP, Littner M, Andrews CP, Tomlinson L, Rinehart M, Denis-Mize K.

Respir Med. 2008 Apr;102(4):479-87. doi: 10.1016/j.rmed.2007.12.019. Epub 2008 Feb 6.

19.

Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents.

Martin BG, Ratner PH, Hampel FC, Andrews CP, Toler T, Wu W, Faris MA, Philpot EE.

Allergy Asthma Proc. 2007 Mar-Apr;28(2):216-25.

PMID:
17479608
20.

Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.

Martin BG, Andrews CP, van Bavel JH, Hampel FC, Klein KC, Prillaman BA, Faris MA, Philpot EE.

Ann Allergy Asthma Immunol. 2006 Jun;96(6):851-7.

PMID:
16802774
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk